Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal Dishevelled 2 phospho S143 antibody. Suitable for WB and reacts with Mouse, Human samples. Cited in 13 publications.
View Alternative Names
Segment polarity protein dishevelled homolog DVL-2, Dishevelled-2, DSH homolog 2, DVL2
- WB
Lab
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (AB124933)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (ab124933) at 1/5000 dilution
Lane 1:
Untreated HEK293 cell lysate at 10 µg
Lane 2:
Alkaline phosphatase treated HEK293 cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 78 kDa
Observed band size: 95 kDa
false
- WB
Lab
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (AB124933)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (ab124933) at 1/1000 dilution
Lane 1:
Untreated F9 cell lysate at 10 µg
Lane 2:
Alkaline phosphatase treated F9 cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 78 kDa
Observed band size: 95 kDa
false
- WB
Unknown
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (AB124933)
All lanes:
Western blot - Anti-Dishevelled 2 (phospho S143) antibody [EPNCIR145] (ab124933) at 1/1000 dilution
Lane 1:
F9 cell lysate untreated at 10 µg
Lane 2:
F9 cell lysate treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 95 kDa
false
Reactivity data
Product details
This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Kyung Lee. View antibodies from NCI Center for Cancer Research Collaboration.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Bioactive materials 43:255-272 PubMed39386219
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 7: PubMed39366759
2024
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 30:2402-2415 PubMed34274973
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:17443 PubMed33060778
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 8:465 PubMed32587859
2020
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:3413-3428 PubMed31922321
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 18:3845-3856 PubMed31579410
2019
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 9:3707-3722 PubMed31281508
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:2356 PubMed31142743
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:2715 PubMed29426949
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com